Outcomes for young children with molecularly defined ependymoma treated on the multi-institutional SJYC07 clinical trial.

Santhosh A. Upadhyaya,Giles W. Robinson,Brent A. Orr,Arzu Onar-Thomas,Catherine A. Billups,Gregory T. Armstrong,Zsila Sadighi,Tim Hassall,Daniel C. Bowers,Anne Bendel,John R. Crawford,Sonia Partap,Paul Klimo,Julie H. Harreld,Christopher Tinkle,Daniel J. Indelicato,Frederick A. Boop,Thomas E. Merchant,David W. Ellison,A. Gajjar

Outcomes for young children with molecularly defined ependymoma treated on the multi-institutional SJYC07 clinical trial.

2018

10548Background: Retrospective reports of poor outcomes of ependymoma (EPN) subgroups, posterior fossa A (PF-EPN-A) and supratentorial C11orf95–RELA (ST-EPN-RELA), need confirmation in prospective ...

Keywords:

Clinical trial
Ependymoma
Pathology
Physical therapy
Medicine
Pediatrics
posterior fossa

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations